See also this year's filing and all EDGAR filings for this company.
PDF Report 0001235007_2017_Endocyte_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001235007, Endocyte INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 140,255,710 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,205,077 |
| 3 | remainder_Assets | 33,567 |
| 4 | LiabilitiesCurrent | 5,562,174 |
| 5 | LiabilitiesNoncurrent | 2,873 |
| 6 | remainder_Liabilities | 781,944 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 17,207,939 |
| 9 | ResearchAndDevelopmentExpense | 27,374,111 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,080,779 |
| 13 | remainder_ComprehensiveNetIncome | 47,343 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 143,494,354 |
| 1 | Liabilities | 6,346,991 |
| 2 | Expenses | 44,582,050 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 137,147,363 |
| 5 | NetIncome | -43,501,271 |
| 6 | ComprehensiveNetIncome | -43,477,600 |
| 7 | BaseVar | 97,775,758 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.41 |
| 9 | EconomicCapitalRatio | 3.97 |